Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Debouck

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|March 4, 1994
Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitorsP B Taylor, J S Culp, C Debouck, et al.
Journal of Molecular Biology|December 25, 1984
Mutations that alter the DNA binding site for the bacteriophage lambda cII protein and affect the translation efficiency of the cII geneN Place, K Fien, M E Mahoney, et al.
Journal of Virology|August 1, 1991
An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gagR A Littaua, M B Oldstone, A Takeda, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individualsP Reiss, F de Wolf, C L Kuiken, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 1995
The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1D W Rodgers, S J Gamblin, B A Harris, et al.
Biochemistry|September 6, 1991
Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 proteaseS K Grant, I C Deckman, M D Minnich, et al.
International Orthopaedics|August 3, 2001
The prevalence of mycotoxins in Kashin-Beck diseaseE Haubruge, C Chasseur, C Debouck, et al.
Biochemistry|November 6, 1992
Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 proteaseT A Tomaszek, M L Moore, J E Strickler, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 22, 1999
Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralizationM Gowen, F Lazner, R Dodds, et al.
Biochemistry|August 10, 1993
Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysisS S Abdel-Meguid, B Zhao, K H Murthy, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|March 4, 1994
Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitorsP B Taylor, J S Culp, C Debouck, et al.
Journal of Molecular Biology|December 25, 1984
Mutations that alter the DNA binding site for the bacteriophage lambda cII protein and affect the translation efficiency of the cII geneN Place, K Fien, M E Mahoney, et al.
Journal of Virology|August 1, 1991
An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gagR A Littaua, M B Oldstone, A Takeda, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individualsP Reiss, F de Wolf, C L Kuiken, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 1995
The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1D W Rodgers, S J Gamblin, B A Harris, et al.
Biochemistry|September 6, 1991
Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 proteaseS K Grant, I C Deckman, M D Minnich, et al.
International Orthopaedics|August 3, 2001
The prevalence of mycotoxins in Kashin-Beck diseaseE Haubruge, C Chasseur, C Debouck, et al.
Biochemistry|November 6, 1992
Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 proteaseT A Tomaszek, M L Moore, J E Strickler, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 22, 1999
Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralizationM Gowen, F Lazner, R Dodds, et al.
Biochemistry|August 10, 1993
Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysisS S Abdel-Meguid, B Zhao, K H Murthy, et al.
Pageof 8